Literature DB >> 22001274

Bacterial expression of Crimean-Congo hemorrhagic fever virus nucleoprotein and its evaluation as a diagnostic reagent in an indirect ELISA.

Rudo R Samudzi1, Patricia A Leman, Janusz T Paweska, Robert Swanepoel, Felicity J Burt.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne viral zoonosis distributed widely in Africa, Asia, Russia and the Balkans. The emergence and re-emergence of CCHFV emphasize the importance of increasing both human and veterinary surveillance and developing diagnostic capacity. Recombinant CCHFV nucleocapsid protein (NP) has been expressed using insect cells and mammalian cells and used as a diagnostic tool but bacterial expression has not been described previously. The S gene of CCHFV was codon optimized and the NP expressed in Escherichia coli from the synthetic gene. The protein was reacted against serum samples collected from confirmed CCHFV patients at varying intervals after the onset of illness from acute to convalescent stages using both an ELISA and a Western blot. To confirm that the protein was able to induce a humoral antibody response that could be detected using CCHFV antigen derived from live virus, mice were immunized and serum samples were tested using IF slides prepared from CCHFV infected Vero cells. The recombinant antigen was able to detect IgG antibody in acute and convalescent sera. In addition, a detectable IgG antibody response was induced in mice immunized using NP. The results suggest that proteins expressed in a bacterial system lacking post-translational modifications can be used in ELISA to detect IgG antibody against CCHFV in human sera which may be used for routine diagnosis and seroepidemiology.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001274     DOI: 10.1016/j.jviromet.2011.09.023

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

1.  Detection of IgG antibody against Crimean-Congo haemorrhagic fever virus using ELISA with recombinant nucleoprotein antigens from genetically diverse strains.

Authors:  A Rangunwala; R R Samudzi; F J Burt
Journal:  Epidemiol Infect       Date:  2013-12-13       Impact factor: 4.434

2.  Identification of human linear B-cell epitope sites on the envelope glycoproteins of Crimean-Congo haemorrhagic fever virus.

Authors:  D Goedhals; J T Paweska; F J Burt
Journal:  Epidemiol Infect       Date:  2014-09-04       Impact factor: 4.434

3.  Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).

Authors:  Dongliang Liu; Yang Li; Jing Zhao; Fei Deng; Xiaomei Duan; Chun Kou; Ting Wu; Yijie Li; Yongxing Wang; Ji Ma; Jianhua Yang; Zhihong Hu; Fuchun Zhang; Yujiang Zhang; Surong Sun
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

4.  Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection.

Authors:  Dominique Goedhals; Janusz T Paweska; Felicity J Burt
Journal:  PLoS Negl Trop Dis       Date:  2017-12-19

5.  Serological evidence of rift valley fever Phlebovirus and Crimean-Congo hemorrhagic fever orthonairovirus infections among pygmies in the east region of Cameroon.

Authors:  Serge Alain Sadeuh-Mba; Gide Martial Yonga Wansi; Maurice Demanou; Antoine Gessain; Richard Njouom
Journal:  Virol J       Date:  2018-04-06       Impact factor: 4.099

6.  Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.

Authors:  Petra Emmerich; Angela Mika; Ronald von Possel; Anne Rackow; Yang Liu; Herbert Schmitz; Stephan Günther; Kurtesh Sherifi; Barie Halili; Xhevat Jakupi; Lindita Berisha; Salih Ahmeti; Christina Deschermeier
Journal:  PLoS Negl Trop Dis       Date:  2018-03-26

7.  Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus.

Authors:  Abulimiti Moming; Daerken Tuoken; Xihong Yue; Wanxiang Xu; Rong Guo; Dongliang Liu; Yijie Li; Zhihong Hu; Fei Deng; Yujiang Zhang; Surong Sun
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

8.  Diagnostic assays for Crimean-Congo hemorrhagic fever.

Authors:  Jessica Vanhomwegen; Maria João Alves; Tatjana Avšič Zupanc; Silvia Bino; Sadegh Chinikar; Helen Karlberg; Gülay Korukluoğlu; Miša Korva; Masoud Mardani; Ali Mirazimi; Mehrdad Mousavi; Anna Papa; Ana Saksida; Batool Sharifi-Mood; Persofoni Sidira; Katerina Tsergouli; Roman Wölfel; Hervé Zeller; Philippe Dubois
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883

9.  Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models.

Authors:  Touraj Aligholipour Farzani; Katalin Földes; Koray Ergünay; Hakan Gurdal; Aliye Bastug; Aykut Ozkul
Journal:  Vaccines (Basel)       Date:  2019-09-16

10.  Development of Multispecies Recombinant Nucleoprotein-Based Indirect ELISA for High-Throughput Screening of Crimean-Congo Hemorrhagic Fever Virus-Specific Antibodies.

Authors:  Neha Shrivastava; Ambuj Shrivastava; Sandeep M Ninawe; Shashi Sharma; Jyoti S Kumar; Syed Imteyaz Alam; Amit Kanani; Sushil Kumar Sharma; Paban Kumar Dash
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.